Relevance relative to the call for proposals
Aspects relating to the research project

21
The main aim is to assess the effectiveness of introducing a standardized intervention program 22 for treatment of fragility fracture patients, on the fracture rates and mortality across regions of 23
Norway. 24 25 2.1. Background and status of knowledge 26 27
Epidemiology of fragility fractures 28
Bone fragility is a global health problem, and for largely unknown reasons Norway has the highest 29 rates of fractures in the world. (1;2) As the population ages, the annual number of fractures and 30 associated costs are expected to increase by 50% between 2005 and 2050.
(3;4) If hip fracture rates in 31
Norway remain constant the burden is expected to double towards 2040.
(5) Women and men above 32 50 years of age have a remaining lifetime risk of fractures of 46% and 22%, respectively.
(6) Fragility 33 fractures are associated with a substantial burden of morbidity as pain, loss of function, disability, 34 hospitalization, and long-term nursing care. (7;8) In Europe, about 2.7 million fragility fractures occur 35 every year in men and women, and the direct annual cost of this is estimated to EUR 36 billion. (9) 36 Despite the high economic cost to society and personal cost to affected individuals, osteoporosis 37 prevention is suboptimal, as many patients do not receive available and efficient therapy.
(3) The 38
anti-osteoporosis drugs are readily available and may reduce the risk for future fracture by 30-39 50%.
(10;11) 40 In Norway, about 10 000 subjects over 50 years of age suffer a hip fracture every year, (12;13) 41 and the annual number of forearm fractures is estimated to 15 000. (14;15) As hip fractures are 42 estimated to constituted 20% of all osteoporotic fractures in Europe, (16) this would imply 50 000 43 osteoporotic fractures annually in Norway, but exact number is lacking. Moreover, there is no good 44 estimate of the total costs of osteoporotic fractures in Norway. Folkehelsemeldingen 2012/2013 45 (report from the Norwegian government) refers to hip fractures as one of the most expensive 46 diagnoses for the Norwegian health system, and the total costs during the first year after a hip 47 fracture is estimated to NOK 500.000. (17) In Sweden, the annual costs related to fractures were 48 estimated to SEK 5.6 billion. The pathogenesis and clinical significance of bone fragility 54
The pathogenesis of fractures is multifactorial; genetics, trauma mechanism, falls and bone strength 55 are all important factors.
(19) Women suffer more fractures than men, particularly postmenopausal 56 women, but the risk of recurrent hip fracture is similar given similar remaining life expectancy. 
57
However, compared to women, men have higher mortality after a hip fracture, (20) and the 1-year 58 excess mortality post hip fracture was 2.8 and 4.6 increased in women and men, respectively. 
59
One year after a hip fracture, one of four patients over 50 years of age were no longer alive. 60 61
Assessment and treatment of persons at high risk of fracture 62
Measurement of femoral neck bone mineral density (BMD) by dual energy X-ray absorptiometry 63 (DXA) is the most common approach used to assess fracture risk and is considered the gold 64 standard surrogate for bone strength.
(22;23) However, although a lower BMD is associated with 65 increased risk of fracture, most people with fractures do not have osteoporosis (T score of 2.5 or 66 more standard deviations (SD) below the young normal mean) but osteopenia or normal BMD. regions of Norway will be assessed in register data before intervention. 147 2. The incidence of fragility fractures (hip, proximal humerus and wrist) will be reduced at hospitals 148 with a standardized intervention program compared to hospitals without. 149 3. The mortality rate after fragility fractures (hip, proximal humerus and wrist) will be reduced at 150 hospitals with a standardized program compared to hospitals without. 151 152
Stepped Wedge Cluster Randomized Controlled Trial 153
In this stepped wedge cluster randomized controlled trial, the hospitals are randomized for the order 154 to start of the study. The intervention was planned to start at 4 months interval for 3 clusters 155 (consisting of 2-3 hospitals, Fig. 1 ), until all 7 hospitals have received the intervention. (40;41) Each hospital will be 175 their own control, and endpoints will be compared before and after the introduction of intervention. 176
This stepped wedge cluster randomization design is particular relevant where it would be 177 considered unethical to not deliver or retract the intervention when it is expected to do more good 178 than harm, as here where the intervention is expected to be included as a future standard routine. fingers, toes, face and skull) will be approached by the coordinating nurse, and offered information, 183 assessment, lifestyle advice and treatment for bone fragility, preferable while in-patient are at the 184 hospital, or as out-patients, within 6 weeks after the fracture (see algorithm Fig. 2 ). Lifestyle advice 185 about physical activity, fall prevention, healthy diet, smoking cessation and moderate alcohol 186 intake, will be given, and referral to fall prevention at the hospital or primary care if indicated. 187 compression), and those who suffer a second fracture while using AOD, will be referred for further 253 examination by specialist at the hospital and teriparatide treatment will be considered. 254 255 14. AOD will be prescribed by a hospital physician involved in this project. All patients treated 256 with AOD will be offered a follow-up phone call after 3 months by the nurse and a visit to talk with 257 the nurse after 1 year, to improve the compliance and resilience. 258 259
In brief, at all hospitals, the intervention is a standardized program involving a nurse and physician 260 who offer information, assessment, and treatment if needed in the hospital setting as an integrated 261 part of the fracture treatment. All patients included in this study, will be offered a follow-up 262 appointment to talk with the nurse 1 year after the fracture. The study design is kept simple to make 263 the project realistic and feasible, scientifically, organizationally, in relation to the use of resources. physicians or private x-ray institutes when they fracture. This type of information is available in 281 KUHR. In order to make sure that information on fractures treated outside hospitals is not missed, 282
we want to include KUHR-data. The ICPC-2 diagnosis codes L72-L76 contain relevant information 283 on fractures (Fig. 3) . Norway (UNN, Tromsø). All fracture patients will be offered assessment and treatment as outlined 321 previously. The dedicated FLS nurses will perform weekly systematic searches of all in-patients 322 and out-patients, and approach admitted patients and invite out-patients to participate by letter, SMSand telephone and offer appointment with nurse within 6 weeks. Good routines will be established 324 together with our international collaborators, who have experience from establishing and 325 maintaining such projects. The nurses will provide patients with information about bone fragility, 326 and the impact of their future fracture risk, so they will be well motivated for modifying amendable 327 lifestyle factors such as; physical activity, healthy diet, with sufficient intake of vitamin D and 328 calcium, protein, avoid excess alcohol intake and quit smoking. Follow-up appointment with the 329 nurses after 1 year will be offered for assessment of compliance. A physician will prescribe anti-330 osteoporosis drug (AOD) for those who need it and outlined in the treatment algorithm. 331
2018-2019
Data from registers will be retrieved for the first publications on the incidence of 332 forearm fractures and other low-energy fragility fractures at different hospitals and regions in 333
Norway. The PhD student will take the courses they need for the PhD program. 334 2020 The final papers on the effect of the introduction of the standardized program will be written 335 by the PhD student and researchers. In 2021 the PhD student will defend their theses. 336 337
Research Team 338
The research team has all the qualifications and resources needed to complete the study including 339 equipment, methods and infrastructure, regional, national and international collaborators. Treatment 340 of fracture patients will be coordinated across specialities, as the team includes orthopedic surgeons, 341 endocrinologist, epidemiologists and rheumatologists with longstanding experience in treatment of 342 patients with fractures and/or osteoporosis; some are world capacities in the field. This 343 collaboration will promote national and international network building. The international 344 cooperation will ensure that the intervention will be well planned, organized and executed. 345
Initiatives are taken at seven hospitals, particular from the Norwegian Orthopedic Surgeon Society 346 of Osteoporosis and Bone Health (FOB), and four universities with a range of experts involved: 347 348
Oslo University Hospital, Prof. Lars Nordsletten, orthopedic surgeon (Ullevål), Frede Frihagen, 349 expect this research to provide a basis for ensuring high-quality, safe and effective services for the 394 many fracture patients. The evidence from this project will be used to develop national guidelines 395 for secondary fracture prevention to break the fragility fracture cycle and improve patient care. 396 397 3.2 Relevance and benefit to society 398 Bone fragility is currently largely ignored by treating physicians, both specialists and general 399
practitioners. This project is a unique possibility to test the hypothesis that a new standardized 400 program for bone fragility assessment and treatment will prevent secondary fractures and reduce 401 mortality rates in both genders. We believe this will be useful to establish a clinical management 402 strategy, to correctly target treatment to individuals who need it, to reduce the burden of bone 403 fragility in the society, and promote bone health and life quality by advancing age. We wish 404 through this research to contribute to increased understanding of the importance of bone fragility, 405
and offer assessment and treatment to those who need it, and help focus on osteoporosis. 406 407 3.3 Environmental impact No environmental impact expected as a result of this project. 408 409
Ethical perspectives 410
Approval by the ethics committee has been achieved for linkage of data from national registers for 411 the main study, with exemption from obtaining of consent (REK 2015/334 for the period 2015-412 2025). We will apply for access of the data from each of the national registers. The linkage of the 413 register data will be performed by NPR, who will provide us with anonymous data that will be 414 stored safely at TSD, at the University of Oslo (see method section). 415 416 3.5 Gender issues (Recruitment of women, gender balance and gender perspectives) 417
Of fracture patients 2/3 are women and 1/3 men, but men have higher mortality after a hip fracture. 418
The nurses at each hospital will approach patients of both genders. Analyses will be gender 419 stratified, and women and men will be compared. Moreover, the project will promote the Research 420
Council's general objectives to increase recruitment of female collaborators and improve gender 421 balance in projects, to obtain an equal gender distribution. 422 423
Dissemination and communication of results
424
Dissemination plan 425
The scientific results will be presented and published in peer-review national journals and highly 426 renowned international journals and at local, national and international meetings. The results will 427 also be presented for the public in local meetings, through media and in cooperation with patientorganisations. Authorship for the various scientific papers will be according to the Vancouver 429 protocol. If in doubt about authorship, the project steering committee will decide. 430
Communication with users 431
All patients will be informed about the importance of bone fragility and advised about treatment if 432 needed in a face-to-face setting by the coordinating nurses at each of the study sites. All information 433 important to the participant's health and results of this research will be made available for the 434 participants. The nurses and physicians involved in this project will educate patients, staff members 435 and the general population, present results from successful FLS models in other countries, for 436 prevention of secondary fractures and explain the importance of the current research project. 437 438
